Bio-Rad Laboratories (NYSE:BIO.B) Shares Pass Above Fifty Day Moving Average – Should You Sell?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $310.78 and traded as high as $312.75. Bio-Rad Laboratories shares last traded at $312.75, with a volume of 44 shares traded.

Bio-Rad Laboratories Trading Down 0.5%

The company has a current ratio of 5.44, a quick ratio of 3.94 and a debt-to-equity ratio of 0.18. The stock has a market cap of $8.44 billion, a P/E ratio of -12.87 and a beta of 1.01. The business’s fifty day simple moving average is $310.78 and its 200 day simple moving average is $284.15.

Bio-Rad Laboratories (NYSE:BIO.B) last released its quarterly earnings results on Wednesday, October 29th. The company reported $2.26 EPS for the quarter. Bio-Rad Laboratories had a negative net margin of 26.43% and a positive return on equity of 4.19%. The business had revenue of $653.00 million for the quarter.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc is a global provider of innovative products and systems that serve the life science research and clinical diagnostics markets. The company operates through two primary segments: Life Science, which delivers instruments, consumables and software for research applications, and Clinical Diagnostics, which offers quality control materials and reagent systems for blood typing, immunology and molecular testing. Bio-Rad’s product portfolio supports a wide range of applications, including protein analysis, gene expression, cell biology and digital PCR.

In the Life Science segment, Bio-Rad develops and markets technologies such as electrophoresis and imaging systems, chromatography instruments, laboratory consumables and software platforms that streamline experimental workflows.